| Literature DB >> 35633728 |
Chunming Xu1,2, Lingqiang Kong1, Hanfang Gao1, Xiyu Cheng3, Xiumin Wang4,5.
Abstract
The overuse of antibiotics in food animals has led to the development of bacterial resistance and the widespread of resistant bacteria in the world. Antibiotic-resistant bacteria (ARB) and antibiotic-resistant genes (ARGs) in food animals are currently considered emerging contaminants, which are a serious threat to public health globally. The current situation of ARB and ARGs from food animal farms, manure, and the wastewater was firstly covered in this review. Potential risks to public health were also highlighted, as well as strategies (including novel technologies, alternatives, and administration) to fight against bacterial resistance. This review can provide an avenue for further research, development, and application of novel antibacterial agents to reduce the adverse effects of antibiotic resistance in food animal farms.Entities:
Keywords: alternatives; antibiotics; bacterial resistance; food animals; strategies
Year: 2022 PMID: 35633728 PMCID: PMC9133924 DOI: 10.3389/fmicb.2022.822689
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Outlines of antibiotic resistance in food animal farms and risks.
FIGURE 2How bacterial resistance to antibiotics occurs.
Typical antibiotics, antibiotic-resistant genes (ARGs), and antibiotic -resistant bacteria (ARB) in food animal farms.
| ARB | Antibiotics | ARGs |
| Gram-negative bacteria | β-Lactams | |
| Aminoglycosides | ||
| Tetracyclines | ||
| Sulfonamides | ||
| Gram-positive bacteria | MLSB | |
| FCA | ||
| Vancomycin |
| |
| Colistin |
FIGURE 3Multiple pathways involved in ARB and ARGs in the food animal and human health (Koch et al., 2017).
FIGURE 4Strategies to minimize the antibiotic resistance in food animal farms.
Other novel methods to reduce ARB and ARGs.
| Methods | Characteristics | Samples | References |
| Fe2O3 nanoparticles | Efficient and rapid degradation of organic pollutants in water | Antibiotic water |
|
| Photocatalys | Excellent stability and recyclability | Antibiotic wastewater |
|
| Biochar composting | Effectively prevent greenhouse gas emissions and avoid environmental pollution | Mature compost |
|
| Bimetallic nitrogen-doped porous carbon | Renewable energy production and wastewater treatment | Antibiotic wastewater |
|
| Moving bed biofilm reactor (MBBR) system | Efficient process for treating wastewater with poor biodegradability | Antibiotic wastewater |
|
| Microalgal pretreatment | Effective removal of antibiotic residues and achievement of organics | Saline antibiotic wastewater |
|
Diverse reactors to treat antibiotic wastewater.
| Methods | Characteristics | Sources | References |
| Anaerobic membrane bioreactor (AnMBR) | Low energy consumption | Artificially formulated antibiotic wastewater |
|
| Up-flow anaerobic bio-electrochemical system (UBES) | Higher removal performance | Antibiotic wastewater from park and pharmaceutical company |
|
| Expanded granular sludge bed (EGSB) reactor | Low cost, low sludge production and long-term stable operation | Artificially formulated antibiotic wastewater | |
| Osmotic membrane bioreactor (OMBR) | High rejection by the forward osmosis membrane, water reclamation and facilitated nutrients recovery | Synthetic wastewater |
|
| Up-flow blanket filter (UBF) reactor | Economical, exhibited favorable performance | Simulated antibiotic wastewater |
|
| Anoxic/oxic-membrane bioreactor (A/O-MBR) | High removal efficiency of bulk pollutants (such as phosphorus, ARGs and antibiotics) | Synthetic wastewater |
|
Some antibiotics prohibited from use in food animals.
| Antibiotics | Countries | Time |
| All antibiotics as growth promoters | The European Union countries | 2006 |
| Lincomycin hydrochloride, virginiamycin, oleandomycin, and procaine penicillin | The United States | 2016 |
| Chloramphenicol, clenbuterol, diethylstilbestrol, dimetridazole, ipronidazole/other nitroimidazoles, furazolidone/nitrofurazone, sulfonamide, fluoroquinolones, glycopeptides, phenylbutazone, and cephalosporins | FDA | 2017 |
| 11 Antibiotics (including bacitracin zinc, flavomycin, virginiamycin, nosiheptide, avilamycin, kitasamycin, oxytetracycin calcium, aureomycin, enlamycin, bacitracin methylene disalicylate, and quinolone premix | China | 2020 |